HOLMDEL, NJ – April 7, 2009 –
Sparta Systems, Inc., the maker of TrackWise software, and the market leader in enterprise quality and compliance management, today announced that Chiesi Farmaceutici SPA, a pharmaceutical company dedicated to the research, development and commercialization of ethical therapeutic products, has selected its TrackWise Enterprise Quality Management System (EQMS) to reduce the cost of compliance and streamline organizational quality practices. Chiesi will leverage the TrackWise software specifically to manage quality processes including audits, non-conformance, corrective and preventative actions and workflow verification.
Stringent regulations guide every aspect of the development and production processes for pharmaceutical manufacturers, requiring companies to implement rigorous procedures for documentation and auditing. With the global economic downturn already limiting organizational resources, companies are recognizing the need to streamline processes and reduce the cost of compliance while maintaining high quality standards.
Like most life sciences companies, Chiesi previously relied on a paper-based model for tracking all corporate quality assurance (QA) processes. In order to more efficiently manage these crucial procedures, Chiesi sought an automated system that would reduce the time spent validating processes and identifying irregularities. By selecting Sparta Systems’ TrackWise software to manage audit workflow, Chiesi now expects to reduce cycle times and normalize data between departments, improving visibility by making reporting simpler and more accurate.
“Given Sparta Systems’ fundamental knowledge of the life sciences industry, quality practices and reporting requirements, Chiesi understood it had a partner that would leverage industry best practices to boost our compliance initiatives across the organization,” said Dr. Francesca Bacchini, corporate QA research and development head of Chiesi Farmaceutici Group. “In choosing the TrackWise Quality Management System to streamline audit processes, we expect to see a quick return on our investment, expanding the solution across our entire quality assurance unit.”
“TrackWise will enable Chiesi to improve quality and identify operational risks by facilitating the full lifecycle management of audits and help ensure that their findings are resolved in a timely and effective manner,” said Yaniv Vardi, general manager, Sparta Systems Europe. “Global organizations realize that in using TrackWise they can more efficiently manage quality across the global supply chain, reducing the cost of compliance and paving the way for future growth.”
About Chiesi Farmaceutici SPA
Chiesi Farmaceutici is a European pharmaceutical group with its headquarters in Parma, Italy. The Group's turnover reached 749 million Euro in 2008. Chiesi has marketing and sales organizations in all major European markets and distributes its products in over 50 countries worldwide through its affiliates and partners. The Group employs 3,243 people of whom approximately 300 are involved in research; besides the already existing R&D facilities in Italy, France, and the United States, a new research laboratory was established in Chippenham (UK) during 2008.
More information about the Chiesi Group, can be found at
www.chiesigroup.com
.
About Sparta Systems
Sparta Systems, Inc. is the industry leader for global quality and compliance management systems. Its TrackWise product is a Web-based software application used by quality, manufacturing, and regulatory affairs professionals to manage quality and compliance issues across the enterprise. The company has more than 14 years of experience and an extensive customer base in the life sciences and other highly regulated industries. Sparta Systems offers its customers a complete solution for global quality management needs, including the onsite support required throughout the project lifecycle. More information about Sparta Systems can be found at
www.spartasystems.com
.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
WCG Randomized 1,600 Participants for RSV Vaccine Trial
October 31st 2024A top 5 sponsor turned to WCG to recruit expecting mothers for its Phase III RSV vaccine trial. WCG support covered multiple countries and contributed almost one third of overall randomizations in the supported countries, bringing the study in ahead of schedule despite delays due to COVID-19 impacts on RSV seasonality. The sponsor met study timeline past enrollment by continuing to work with WCG’s retention support.